Cargando…
Hypoxia Mimetic Agents for Ischemic Stroke
Every year stroke claims more than 6 million lives worldwide. The majority of them are ischemic stroke. Small molecule-based therapeutics for ischemic stroke has attracted a lot of attention, but none has been shown to be clinically useful so far. Hypoxia-inducible factor-1 (HIF-1) plays a crucial r...
Autores principales: | Davis, Charles K., Jain, Saurabh A., Bae, Ok-Nam, Majid, Arshad, Rajanikant, G. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331394/ https://www.ncbi.nlm.nih.gov/pubmed/30671433 http://dx.doi.org/10.3389/fcell.2018.00175 |
Ejemplares similares
-
Editorial: The Development of New Classes of Hypoxia Mimetic Agents for Clinical Use
por: Chen, Ruoli, et al.
Publicado: (2019) -
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
por: Mitroshina, Elena V., et al.
Publicado: (2021) -
Native and Bioengineered Exosomes for Ischemic Stroke Therapy
por: Khan, Haroon, et al.
Publicado: (2021) -
Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke
por: Davis, Charles K, et al.
Publicado: (2016) -
Dual Effects of Presynaptic Membrane Mimetics on α-Synuclein Amyloid Aggregation
por: Lin, Yuxi, et al.
Publicado: (2022)